Towards molecular selectivity in pharmacoimaging: Comment on van den Bosch and Cools.

Timothy Lawn1,2, Mitul A Mehta2

  • 1Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States.

Summary

This study validates molecular-enriched fMRI (functional Magnetic Resonance Imaging) for tracking dopamine networks and individual differences in dopamine synthesis. It highlights methodological considerations for future molecular-informed neuroimaging research.